Ondine Biomedical treats first patients in nasal photodisinfection US Phase 2 trial for the prevention of post-operative infections
07 févr. 2022 02h15 HE
|
Ondine Biomedical Inc.
Vancouver, Canada, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Post-operative infections occur in up to 300,000 patients per year in the United States and cost the US healthcare system tens of billions of...